Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
166.00
-2.35 (-1.40%)
Oct 12, 2026, 4:00 PM EDT - Market closed
Axsome Therapeutics Employees
Axsome Therapeutics had 1,346 employees as of June 30, 2026. The number of employees increased by 500 or 59.10% compared to the same quarter last year. That makes Axsome Therapeutics the 12,793rd largest employer in the world and 1,999th in the United States.
Employees
1,346
Change
500
Growth
59.10%
Revenue / Employee
$576,946
Profits / Employee
-$142,380
Market Cap
8.70B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,346 | 500 | 59.10% |
| Mar 31, 2026 | 1,220 | 508 | 71.35% |
| Dec 31, 2025 | 925 | 242 | 35.43% |
| Sep 30, 2025 | 816 | 209 | 34.43% |
| Jun 30, 2025 | 846 | 257 | 43.63% |
| Mar 31, 2025 | 712 | 143 | 25.13% |
| Dec 31, 2024 | 683 | 138 | 25.32% |
| Sep 30, 2024 | 607 | 105 | 20.92% |
| Jun 30, 2024 | 589 | 167 | 39.57% |
| Mar 31, 2024 | 569 | 176 | 44.78% |
| Dec 31, 2023 | 545 | 162 | 42.30% |
| Sep 30, 2023 | 502 | 150 | 42.61% |
| Jun 30, 2023 | 422 | 224 | 113.13% |
| Mar 31, 2023 | 393 | 277 | 238.79% |
| Dec 31, 2022 | 383 | 275 | 254.63% |
| Sep 30, 2022 | 352 | 246 | 232.08% |
| Jun 30, 2022 | 198 | 105 | 112.90% |
| Mar 31, 2022 | 116 | 46 | 65.71% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Ionis Pharmaceuticals | 1,480 |
| Twist Bioscience | 979 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
| TG Therapeutics | 399 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
AXSM News
- 4 days ago - Axsome Therapeutics price target lowered to $295 from $297 at RBC Capital - TheFly
- 5 days ago - Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2 - GlobeNewsWire
- 13 days ago - Axsome Therapeutics price target lowered to $267 from $280 at Deutsche Bank - TheFly
- 17 days ago - Axsome Therapeutics price target lowered to $247 from $251 at Morgan Stanley - TheFly
- 19 days ago - Axsome Therapeutics assumed with a Buy at Truist - TheFly
- 21 days ago - Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer's Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer's Day - GlobeNewsWire
- 25 days ago - Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026 - GlobeNewsWire
- 26 days ago - Axsome Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts